Op-ed: I promised to fight for common-sense policies rooted in our core conservative principles
By State Rep. Cody Huneycutt (R-NC-67) | Published November 18, 2025 in NC Political News
When I ran for office, I promised that I would fight for common-sense policies rooted in our core conservative principles. That means protecting our citizens and ensuring that we keep the good-paying jobs that sustain our communities. Right now, I’m concerned about how upcoming changes to Medicare Part D reimbursement will affect long-term care pharmacies in our state.
Here’s why these matters: In North Carolina, over 160,000 beneficiaries of Medicare Part D have long-term care needs, meaning they live with chronic diseases or illnesses and can no longer fully care for themselves. These residents depend on the state’s 54 specialized LTC pharmacies to manage their complex medication regimens which can average 12-13 prescriptions daily per person.
Now, you might be thinking, “What’s the difference between these pharmacies and the one I go to?” It’s a fair question. Long-term care pharmacies are fundamentally different from the retail pharmacies most of us use. These pharmacies mainly serve nursing homes and assisted living facilities, providing round the clock emergency medication access. They deliver medications across long distances, manage specialized packaging, and handle the complex medical needs of long-term care patients. They also help nursing homes and assisted living facilities stay in compliance with federal law that requires these facilities to have pharmaceutical services.
But starting January 1, 2026, many of North Carolina’s long-term care pharmacies will face a serious threat to their financial viability due to changes in Medicare Part D reimbursement. The Biden Administration’s Inflation Reduction Act directed the federal government to negotiate prices of certain high-cost brand-name drugs directly with drug companies. The promise was lower drug prices for seniors. And while I support efforts to lower drug costs, the law failed to account for its impact on the pharmacies that actually dispense these medications.
Here’s the problem: Long-term care pharmacies rely on these well known named medications as well as lesser known medications and they depend on both. When you eliminate that margin, these pharmacies won’t be able to keep their doors open and serve the patients who need their specialized care.
And here’s the reality—current reimbursement structures simply don’t adequately pay these pharmacies for what it actually costs to provide full time day in and day out care, manage complicated prescription loads, and serve patients across North Carolina’s rural areas. Without proper compensation, these pharmacies will be forced to shut down.
Let me be clear about what happens when a long-term care pharmacy closes. It’s not just an inconvenience—it triggers a cascade of closures and failures. Nursing homes lose their ability to comply with federal regulations and end up closing. Seniors are forced to relocate far from their families and the facilities and communities they know. And good-paying jobs for pharmacists, technicians, nurses, and care staff disappear from our communities.
Consider this, in rural areas where a single pharmacy may serve multiple facilities across several counties, just one closure affects the whole web of care.
That’s why we need immediate action—whether through legislation or administrative measures—to protect seniors’ access to the pharmacy care they depend on. I strongly support the Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031) as a critical step toward solving this problem.
This bill was introduced by Representatives Beth Van Duyne (R-TX) and addresses this challenge by establishing a targeted supplemental supply fee for prescription drugs subject to Medicare-negotiated prices. Modeled after an existing Medicare Part B supply fee, this solution will help ensure long-term care pharmacies are properly compensated so they can continue delivering the round-the-clock, specialized care that vulnerable patients rely on.
I’m calling on Congress and the Administration to act quickly—either through this legislation or by using the statutory authority CMS already has through a demonstration project or waiver program—to prevent a crisis in long-term care pharmacy access.
This is about protecting our most vulnerable neighbors and preserving good jobs in our communities.
Read the full article on NC Political News here
Recent Posts
-
NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow
With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.
The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.
-
Pharmacies To Face Low Cash Flow For MFP Drugs Until Fixes Emerge
A bill introduced last year aiming to ensure long-term care (LTC) pharmacies can continue to supply and dispense Medicare Part D drugs despite lower prices resulting from the price negotiation program will need to be tweaked to ensure the intended relief is retroactive, according to Alan Rosenbloom, executive director of the Senior Care Pharmacy Coalition (SCPC).
-
SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform: “SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.